Are cabergoline and bromocriptine the same medicine?

Cabergoline and bromocriptine are not the same drugs; there are clear differences between them. Cabergoline and bromocriptine differ in the composition and structure of the drugs. Cabergoline is a synthetic ergot derivative, and bromocriptine (commonly bromocriptine tosylate) is a dopamine receptor agonist in the hypothalamus and pituitary gland.

Cabergoline works primarily through strong, long-acting and selective binding to dopamine receptors, especially D2 receptors. This makes cabergoline highly effective in the treatment of hyperprolactinemia, Parkinson's disease, etc.

Bromocriptine can reduce the secretion of prolactin, thereby restoring the normal menstrual cycle, and is used to treat prolactin-dependent menstrual cycle disorders, infertility, polycystic ovary syndrome, hyperprolactinoma and other diseases.

There are also differences in adverse effects between the two drugs. Possible adverse effects of cabergoline include nausea, vomiting, drowsiness, and constipation. The adverse reactions of bromocriptine are more extensive, including headache, nausea, vomiting, orthostatic hypotension, fatigue and dizziness. In high doses, bromocriptine may also cause symptoms such as dry mouth, hallucinations, and movement disorders.

Due to differences in their mechanisms of action and adverse effects, cabergoline and bromocriptine have different clinical applications. Cabergoline is often viewed as an alternative to bromocriptine and may have superior efficacy and fewer side effects in the treatment of certain diseases. For example, cabergoline may be a better treatment option for patients who are resistant or intolerant to bromocriptine.

To sum up, cabergoline and bromocriptine are not the same drugs. They have significant differences in drug ingredients, mechanism of action, efficacy and adverse reactions. Therefore, when using these two drugs, you should make a reasonable choice based on the patient's specific illness and physical condition, and follow the doctor's guidance for medication.